World News: 22:27 GMT Wednesday 16th May 2018. [GW Pharmaceuticals plc via Thomson Reuters ONE via SPi World News]
-First dose-rangingstudy comparingpharmaceutical formulation ofcannabidiol to placebo as add-on therapy inLennox-Gastaut syndrome a rare severe and difficult to treat form of childhood-onset epilepsy - -Both doses significantly r educed ...
Thomson Reuters: 22:27 GMT Wednesday 16th May 2018
SPi News is published by Sector Publishing Intelligence Ltd.
© Sector Publishing Intelligence Ltd 2018. [Admin Only]
Sector Publishing Intelligence Ltd.
Agriculture House, Acland Road, DORCHESTER, Dorset DT1 1EF United Kingdom
Registered in England and Wales number 0751938.